Payzin, K. B. Et Al. 2014. JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.14, no.6 , 525-533.

Payzin, K. B., Savasoglu, K., ALACACIOĞLU, İ., Ozdemirkiran, F., Mutlu, B. B., Bener, S., ... Calli, A. O.(2014). JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.14, no.6, 525-533.

Payzin, Kadriye Et Al. "JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.14, no.6, 525-533, 2014

Payzin, Kadriye B. Et Al. "JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.14, no.6, pp.525-533, 2014

Payzin, K. B. Et Al. (2014) . "JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.14, no.6, pp.525-533.

@article{article, author={Kadriye Bahriye Payzin Et Al. }, title={JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2014, pages={525-533} }